Second Amendment to ADB’s Support to Enhance COVID-19 Vaccine Access
Institutional Document | May 2021
This paper proposes clarifications to the APVAX policy to ensure that ADB can flexibly meet DMC demands for vaccine support under a transparent and systematic framework while also providing adequate resources for non-COVID-19 operations.
- Rapid Response Component Country Ceilings and the Use of the Project Investment Component for COVID-19 Vaccine Procurement
- ADB’s Resource Availability
- Existing Approach to Financing COVID-19 Vaccine Procurement under APVAX
- Proposed Clarifications and Amendments